Corporate news

Grifols Los Angeles site is awarded "Highly Protected Risk (HPR)" status The HPR award recognizes the highest level asite can achieve in terms of prevention and protection
+ info

Grifols Celebrates World Hemophilia Day with Donation of Coagulation Medicines to the World Federation of Hemophilia Three-year commitment of up to 20 million units per year of blood clotting medicines to treat hemophilia patients in developing countries
+ info

Grifols opens new plasma fractionation plant in Spain The company has invested over 20 million euros, doubling its plasma fractionation capacity in Spain
+ info

Highlights

Manufacturing

Manufacturing
We are a solid company with an international dimension.

Corporate Commitment

People
We contribute to improving people's health and wellbeing by offering safe, high quality products produced using the latest environmentally friendly technology.

banner a awards Martín VillarMartín Villar Haemostasis Awards

Grifols is holding the seventh edition of the Martin Villar Awards for Research in Haemostasis. + info

 

get to know us better

2012 Awards Martí Villar